Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells

Battle, 2002, The role of STATs in apoptosis, Current Molecular Medicine, 4, 381, 10.2174/1566524023362456 Berjis, 1986, Selective cytotoxicity of l-canavanine in tumorigenic. Madin-Darby canine kidney T1 cells, Chemico-Biological Interactions, 3, 305, 10.1016/0009-2797(86)90061-X Cheng, 2005, The Akt/PKB pathway: molecular target for cancer drug discovery, Oncogene, 50, 7482, 10.1038/sj.onc.1209088 Chinkwo, 2005, Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells, Journal of Ethnopharmacology, 98, 163, 10.1016/j.jep.2005.01.016 Fernandes, 2004, The antioxidant potential of Sutherlandia frutescens, Journal of Ethnopharmacology, 95, 1, 10.1016/j.jep.2004.05.024 Gericke, 2001, Sutherlandia frutescens, Australian Journal of Medical Herbalism, 13, 9 Greenhalgh, 2001, Negative regulation of cytokine signaling, Journal of Leukocyte Biology, 3, 256 Izevbigie, 2002, Ethanol modulates the growth of human breast cancer cells in vitro, Experimental Biology and Medicine, 4, 260, 10.1177/153537020222700406 Jang, 2002, Arginine antimetabolite l-canavanine induces apoptotic cell death in human Jurkat T cells via caspase-3 activation regulated by Bcl-2 or Bcl-xL, Biochemical and Biophysical Research Communications, 295, 283, 10.1016/S0006-291X(02)00650-2 Joubert, 2003, The effects of prostaglandin A2 on cell growth, cell cycle status and apoptosis induction in HeLa and MCF-7 cells, Cancer Letters, 2, 203, 10.1016/S0304-3835(02)00625-0 Lillie, 1965 Liu, 2005, Negative regulation of NF-kappaB signaling by PIAS1, Molecular and Cellular Biology, 3, 1113, 10.1128/MCB.25.3.1113-1123.2005 Marchesini, 2004, Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells, Journal of Biological Chemistry, 24, 25101, 10.1074/jbc.M313662200 Medical Research Council and National Research Foundation of South Africa, 2002. A toxicity study of Sutherlandia leaf powder (Sutherlandia microphylla) consumption. Final Report 2002. Mills, 2005, African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology, Nutrition Journal, 4, 1, 10.1186/1475-2891-4-19 Pettus, 2002, Ceramide in apoptosis: an overview and current perspectives, Biochimica et Biophysica Acta, 2, 114, 10.1016/S1388-1981(02)00331-1 Reynolds, 2004, Ceramide synthesis and metabolism as a target for cancer therapy, Cancer Letters, 2, 169, 10.1016/j.canlet.2003.08.034 Robinson, 2006, Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J, Journal of the American College of Surgery, 5, 788, 10.1016/j.jamcollsurg.2006.01.007 Ruvolo, 2003, Intracellular signal transduction pathways activated by ceramide and its metabolites, Pharmacological Research, 5, 383, 10.1016/S1043-6618(03)00050-1 Shklar, 1998, Mechanism of cancer inhibition by anti-oxidant nutrients, Oral Oncology, 34, 24, 10.1016/S1368-8375(97)00060-2 Smyth, 2005, 397 Sounni, 2005, Membrane type-matrix metalloproteinases and tumor progression, Biochimie, 3, 329, 10.1016/j.biochi.2004.07.012 Stephanou, 2003, STAT-1: a novel regulator of apoptosis, International Journal of Experimental Pathology, 6, 239 Swaffar, 1995, Combination therapy with 5-fluorouracil and l-canavanine: in vitro and in vivo studies, Anticancer Drugs, 4, 586, 10.1097/00001813-199508000-00012 Tai, 2004, In vitro culture studies of Sutherlandia frutescens on human tumor cell lines, Journal of Ethnopharmacology, 1, 9, 10.1016/j.jep.2004.02.028 Van Wyk, 2000 Van Wyk, 1997 Wajant, 2004, TRAIL and NFκB signaling, a complex relationship, Vitamins and Hormones, 67, 101, 10.1016/S0083-6729(04)67007-5 Weldon, 2002, Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray, Surgery, 2, 293, 10.1067/msy.2002.125389 Wolff, 1994, Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction, Journal of Biological Chemistry, 30, 19605, 10.1016/S0021-9258(17)32212-3